Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1678
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19357552 | DUAL-SPECIFIC BINDING MOLECULE USEFUL FOR ISOLATING SPECIFIC BLOOD CELLS | Non-Final OA | ImmunityBio, Inc. |
| 17327872 | METHOD OF PRODUCING CELL-CONTAINING CONTAINER | Final Rejection | RICOH COMPANY, LTD. |
| 16975987 | NANOPATTERNING FOR CONTROLLING CELL CYTOSKELETON | Final Rejection | NORTHWESTERN UNIVERSITY |
| 18288345 | VIRAL VECTOR PRODUCTION SYSTEM | Non-Final OA | Novartis AG |
| 17189967 | TDP-43 IN DEGENERATIVE DISEASE | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 17282117 | MODULAR BIOFABRICATION PLATFORM FOR DIVERSE TISSUE ENGINEERING APPLICATIONS AND RELATED METHOD THEREOF | Non-Final OA | University of Virginia Patent Foundation |
| 16511431 | Decellularized Tissue as a Microcarrier for Cell Culture and Expansion | Final Rejection | UNIVERSITY OF SOUTH CAROLINA |
| 18546761 | Methods of Expanding Cholangiocytes | Non-Final OA | Cambridge Enterprise Limited |
| 18575265 | DNA ORIGAMI STRUCTURE AND PROTEIN NANOPORE CONSTRUCT | Non-Final OA | Illumina, Inc. |
| 17055946 | METHODS AND COMPOSITIONS FOR GENERATING CELLS OF ENDODERMAL LINEAGE AND BETA CELLS AND USES THEREOF | Final Rejection | Washington University |
| 18057026 | Methods for Printing Functional Human Neural Tissue | Final Rejection | Wisconsin Alumni Research Foundation |
| 17545416 | METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 17119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | Non-Final OA | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
| 16707681 | PRE-SHAPED ALLOGRAFT IMPLANT FOR RECONSTRUCTIVE SURGICAL USE AND METHODS OF MANUFACTURE AND USE | Non-Final OA | Allosource |
| 17799870 | Method for providing personalized cells with chimeric antigen receptors (CAR) against tumor microenvironment cells | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy